Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1649186

Prostatis Group LLC

Wealth managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$429.4M
Reported positions
190
Holdings vs S&P 500, 3 yrs
—
Assets under management
$605.4M

Prostatis Group LLC is a wealth manager that reported 190 positions worth $429.4M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Thor Finl Technologies Tr (THIR, 16.8%), Amplify ETF Tr (DIVO, 4.9%), Invesco Qqq Tr (QQQ, 3.9%).

Prostatis Group LLC holdings largest 50 of 190 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Prostatis Group LLC 13F holdings
Stock% of 13F valueShare changeReported value
THIRThor Finl Technologies Tr16.8%-1.3%$72.1M
DIVOAmplify ETF Tr4.9%-2.5%$20.9M
QQQInvesco Qqq Tr3.9%-20.0%$16.6M
VUGVanguard Index Fds2.8%+489.7%$12.0M
IGMIshares Tr2.7%-17.2%$11.6M
AIEDExchange Listed Fds Tr2.7%-22.3%$11.5M
XNTKSpdr Series Trust2.4%-29.5%$10.3M
IYWIshares Tr2.1%-10.1%$9.1M
PWBInvesco Large Cap Growthetf2.1%—$9.0M
BILSpdr Series Trust2.0%+87.3%$8.4M
QRFTExchange Listed Fds Tr1.9%-4.8%$8.3M
IAIIshares Tr1.8%+32.6%$7.7M
XSMOInvesco Exchange Traded Fd T1.7%+3.7%$7.5M
SPMOInvesco Exch Traded Fd Tr II1.7%+4.8%$7.5M
GLDSpdr Gold Tr1.6%+0.0%$6.9M
AAPLApple Inc1.5%+3.0%$6.4M
RSPInvesco Exchange Traded Fd T1.3%+29.7%$5.4M
SPLGSpdr Series Trust1.2%+2.1%$5.2M
EWQIshares Inc1.2%+38.4%$5.1M
EWIIshares Inc1.2%+29.0%$5.1M
EWGIshares Inc1.2%+36.4%$5.1M
FLQHFranklin Templeton ETF Tr1.2%—$5.0M
IVVIshares Tr1.1%-5.4%$4.9M
FTLSFirst Tr Exch Traded Fd III1.1%+5.4%$4.7M
VTVVanguard Index Fds1.1%+7.7%$4.5M
NVDANvidia Corporation1.0%-18.3%$4.3M
MSFTMicrosoft Corp1.0%+11.8%$4.3M
BIVVanguard Bd Index Fds1.0%-4.8%$4.2M
SDVYFirst Tr Exchange Traded Fd1.0%+5.2%$4.1M
SPHDInvesco Exch Traded Fd Tr II0.9%+17.0%$3.9M
FNDXSchwab Strategic Tr0.9%+9.1%$3.8M
RDVIFirst Tr Exchange-Traded Fd0.9%-10.0%$3.7M
XOMExxon Mobil Corp0.9%+14.0%$3.7M
GCOWPacer Global Cash Cows Dividend ETF0.8%-3.5%$3.6M
SJNKState Street SPDR Bloomberg Short Term H0.8%—$3.3M
AMZNAmazon Com Inc0.7%+1.6%$3.2M
GOOGLAlphabet Inc0.7%+8.1%$3.0M
PVALPutnam Focused Large Capvalue ETF0.6%-52.9%$2.7M
BSVVanguard Bd Index Fds0.6%-4.9%$2.7M
SPCXSpace Exploration Techn Corp0.6%—$2.7M
VOXVanguard Telecommunication Ser0.6%-24.8%$2.7M
FPEFirst Tr Exch Traded Fd III0.6%-4.0%$2.5M
IGLDFirst Tr Exchange-Traded Fd0.6%+14.3%$2.4M
RYTInvesco Exchange Traded Fd T0.5%—$2.2M
IJSIshares Tr0.5%-2.5%$2.2M
QQQMInvesco Exch Traded Fd Tr II0.5%—$2.1M
GSIEGoldman Sachs ETF Tr0.5%-0.8%$2.1M
NOCNorthrop Grumman Corp0.5%—$2.1M
METAMeta Platforms Inc0.5%-1.5%$2.0M
MUMicron Technology Inc0.5%—$2.0M

What Prostatis Group LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+19.4% /yr
S&P 500 +20.1%
3 years
—
5 years
—

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$429.4M190
Q1 2026$390.7M167
Q4 2025$418.8M165
Q3 2025$399.0M165
Q2 2025$349.4M156
Q1 2025$317.0M151
Q4 2024$343.1M155
Q3 2024$305.6M130
Q2 2023$215.0M250
Q1 2023$189.4M98
Q4 2022$163.9M97
Q3 2022$86.8M64

Questions about Prostatis Group LLC's portfolio

What stocks does Prostatis Group LLC own?

Prostatis Group LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 190 positions worth $429.4M. The largest are Thor Finl Technologies Tr (THIR) at 16.8%, Amplify ETF Tr (DIVO) at 4.9%, Invesco Qqq Tr (QQQ) at 3.9%, Vanguard Index Fds (VUG) at 2.8% and Ishares Tr (IGM) at 2.7%.

What did Prostatis Group LLC buy last quarter?

In Q2 2026, Prostatis Group LLC added Vanguard Index Fds (VUG) (+489.7% shares), Spdr Series Trust (BIL) (+87.3% shares) and Ishares Inc (EWQ) (+38.4% shares), compared with its Q1 2026 filing.

What did Prostatis Group LLC sell last quarter?

In Q2 2026, Prostatis Group LLC cut from its top 50 Ishares Tr (IYG), cut from its top 50 Vanguard Scottsdale Fds (VCIT), cut from its top 50 Ishares Inc (EWY), cut from its top 50 Ishares Tr (EWU), cut from its top 50 Ishares Inc (EWJ), Putnam Focused Large Capvalue ETF (PVAL) (-52.9% shares), Spdr Series Trust (XNTK) (-29.5% shares) and Vanguard Telecommunication Ser (VOX) (-24.8% shares), compared with its Q1 2026 filing.

When is Prostatis Group LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Prostatis Group LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Prostatis Group LLC manage?

Prostatis Group LLC reported $605.4M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $429.4M.